Dara Richardson-heron - Net Worth and Insider Trading

Dara Richardson-heron Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Dara Richardson-heron owns 1 companies in total, including Caribou Biosciences Inc (CRBU) .

Click here to see the complete history of Dara Richardson-heron’s form 4 insider trades.

Insider Ownership Summary of Dara Richardson-heron

Ticker Comapny Transaction Date Type of Owner
CRBU Caribou Biosciences Inc 2021-11-04 director

Dara Richardson-heron Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Dara Richardson-heron Ownership Network

Ownership Network List of Dara Richardson-heron

No Data

Ownership Network Relation of Dara Richardson-heron

Insider Network Chart

Dara Richardson-heron Owned Company Details

What does Caribou Biosciences Inc do?

Who are the key executives at Caribou Biosciences Inc?

Dara Richardson-heron is the director of Caribou Biosciences Inc. Other key executives at Caribou Biosciences Inc include Chief Medical Officer Syed Ali-aamir Rizvi , See Remarks Ryan Fischesser , and See Remarks Steven Kanner .

Caribou Biosciences Inc (CRBU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Caribou Biosciences Inc (CRBU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Caribou Biosciences Inc (CRBU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Caribou Biosciences Inc (CRBU)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Caribou Biosciences Inc Insider Transactions

No Available Data

Dara Richardson-heron Mailing Address

Above is the net worth, insider trading, and ownership report for Dara Richardson-heron. You might contact Dara Richardson-heron via mailing address: C/o Caribou Biosciences, Inc., 29, Berkeley Ca 94710.

Discussions on Dara Richardson-heron

No discussions yet.